DJIA 18,080.14 21.45 0.12%
NASDAQ 5,092.09 36.02 0.71%
S&P 500 2,117.69 4.76 0.23%
market minute promo

64.41 1.16 (1.83%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

TEVA $64.41 1.83%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $63.17
Previous Close $63.25
Daily Range $62.80 - $64.52
52-Week Range $47.36 - $68.75
Market Cap $54.9B
P/E Ratio 42.45
Dividend (Yield) $1.36 (1.8%)
Ex-Dividend Date
Dividend Pay Date
02/17/15
03/03/15
Volume 8,786,656
Average Daily Volume 6,907,446
Current FY EPS $5.16

Sector

Healthcare

Industry

Drug Makers

Teva Pharmaceutical Industries (TEVA) Description

A global pharmaceutical company, Teva develops, produces, and markets generic drugs covering all major treatment categories. Website: http://www.tevapharm.com/

News & Commentary

Big Pharma Comes Under Attack From a New Hedge Fund Strategy

Just in case you thought Big Pharma didn't have enough to worry about, this new hedge fund strategy could bring select Big Pharma companies to their knees.

Teva Puts Forth Its Best Bid To Acquire Mylan

Teva Puts Forth Its Best Bid To Acquire Mylan

TEVA Acquisition Of Mylan Would Produce Generic Powerhouse

Are Biosimilars the Next Big Thing in Biotech?

Biosimilars could soon become a major force in biotech as multiple top-selling biologics lose patent protection. So are biosimilars the next big thing in biotech, or are they overhyped?

Teva-Active Biotech Start Phase II on MS Drug - Analyst Blog

Will Biogen's (BIIB) Earnings Streak Continue in 1Q? - Analyst Blog

Teva Eyeing Mylan For $40 Billion

Mylan Chooses Its Own Adventure

Teva Proposes to Buy Mylan, Sends Shares Up - Analyst Blog

Benzinga's M&A Chatter for Wednesday April 22, 2015

See More TEVA News...

TEVA's Top Competitors

TEVA $64.41 (1.83%)
Current stock: TEVA
JNJ $101.08 (0.62%)
Current stock: JNJ
PFE $35.27 (-0.25%)
Current stock: PFE
RHHBY $36.24 (-0.83%)
Current stock: RHHBY